Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial

Pollock, M Anne; Sturrock, Alison; Marshall, Karen; Davidson, Kate M; Kelly, Christopher J G; McMahon, Alex D; McLaren, E Hamish
October 2001
BMJ: British Medical Journal (International Edition);10/20/2001, Vol. 323 Issue 7318, p891
Academic Journal
Objectives: To determine whether thyroxine treatment is effective in patients with symptoms of hypothyroidism but with thyroid function tests within the reference range, and to investigate the effect of thyroxine treatment on psychological and physical wellbeing in healthy participants. Design: Randomised double blind placebo controlled crossover trial. Setting: Outpatient clinic in a general hospital. Participants: 25 patients with symptoms of hypothyroidism who had thyroid function tests within the reference range, and 19 controls. Methods: Participants were given thyroxine 100 μg or placebo to take once a day for 12 weeks. Washout period was six weeks. They were then given the other to take once a day for 12 weeks. All participants were assessed physiologically and psychologically at baseline and on completion of each phase. Main outcome measures: Thyroid function tests, measures of cognitive function and of psychological and physical wellbeing. Results: 22 patients and 19 healthy controls completed the study. At baseline, patients' scores on 9 out of 15 psychological measures were impaired when compared with controls. Patients showed a significantly greater response to placebo than controls in 3 out of 15 psychological measures. Healthy participants had significantly lower scores for vitality when taking thyroxine compared to placebo (mean (SD) 60 (17) v 73 (16), P<0.01). However, patients' scores from psychological tests when taking thyroxine were no different from those when taking placebo except for a poorer performance on one visual reproduction test when taking thyroxine. Serum concentrations of free thyroxine increased and those of thyroid stimulating hormone decreased in patients and controls while they were taking thyroxine, confirming compliance with treatment. Although serum concentrations of free triiodothyronine increased in patients and controls taking thyroxine, the difference between the response to placebo and to thyroxine was sig...


Related Articles

  • TSH, T4 for diagnosis; thyroxine for therapy.  // New Zealand Doctor;11/16/2005, p21 

    Discusses the diagnosis and treatment of hypothyroidism. Guidelines for interpreting measurement results for thyroid stimulating hormone; Dosage for administering thyroxine; Aim of treatment. INSETS: Refer patients with hypothyroidism;Interpretation of assay results.

  • Renal dysfunction manifesting in subclinical hypothyroidism—a possible role for thyroxine. Asim, Muhammad; El Esnawi, Mohammad // NDT Plus;Jun2010, Vol. 3 Issue 3, p282 

    Renal dysfunction, both acute and chronic, is a recognized association of overt hypothyroidism. We describe a patient who developed renal dysfunction at the stage of subclinical hypothyroidism. We emphasize that renal dysfunction is a reflection of tissue hypothyroidism, dissociated with the...

  • Dyslipidemia in subclinical hypothyroidism and the effect of thyroxine on lipid profile. Asranna, Ajay; Taneja, R. S.; Kulshreshta, Bindu // Indian Journal of Endocrinology & Metabolism;Dec2012 Supplement, Vol. 16, pS347 

    Introduction: Subclinical hypothyroidism (SH) has a prevalence between 4% and 10.5% in various studies. The burden of SH in India is expected to increase with increasing iodine sufficiency. Studies have shown conflicting results concerning not only the degree of lipid changes in SH but also the...

  • Congenital hypothyroidism: follow up of a case for 13 years. Naik, Sudhir M.; S., Ravishankara; Appaji, Mohan; M. K., Goutham; Devi, N. Pinky; Naik, Sarika S. // Online Journal of Otolaryngology;2014, Vol. 4 Issue 2, p1 

    Background/objectives: Congenital hypothyroidism is one of the most common preventable causes of mental retardation in children. The prognosis of infants detected by neonatal screening and started on treatment early is excellent, with intelligence quotients similar to sibling or classmate...

  • Consumptive hypothyroidism in an Egyptian baby with benign neonatal hemangiomatosis: a case report. Metwalley, Kotb Abbass; Farghaly, Hekma Saad // Journal of Medical Case Reports;2013, Vol. 7 Issue 1, p1 

    Introduction: Benign neonatal hemangiomatosis is a condition in which multiple cutaneous hemangiomas appear at birth or shortly thereafter; visceral complications are absent. Here, we report a case of a consumption hypothyroidism in an Egyptian baby with benign neonatal hemangiomatosis. Case...

  • AMIODARONE-INDUCED THYROTOXICOSIS FOLLOWING TREATMENT FOR AMIODARONE-INDUCED HYPOTHYROIDISM. Sung Rae Cho; Seaquist, Elizabeth R. // Acta Endocrinologica (1841-0987);Jul-Sep2007, Vol. 3 Issue 3, p359 

    Amiodarone-induced thyroid dysfunction is common but the development of hyperthyroidism following treatment for amiodarone-induced hypothyroidism is very unusual. We recently saw an elderly man who developed severe thyrotoxicosis four years after diagnosis of and initiation of treatment for...

  • Hypothyroidism. Okosieme, Onyebuchi // Pulse;Sep2015, p88 

    The article discusses the advice given by an endocrinologist on thyroid referral with respect to a question . A person is suffering from hypothyroidism and treated with thyroxine but is there any need to treat with T3(Triiodothyronine)? The consultant replies that the use of T3 needs various...

  • Subclinical Thyroid Disease. Wilson, George R.; Curry Jr., R. Whit // American Family Physician;10/15/2005, Vol. 72 Issue 8, p1517 

    Subclinical thyroid dysfunction is defined as an abnormal serum thyroid-stimulating hormone level (reference range: 0.45 to 4.50 µU per mL) and free thyroxine and triiodothyronine levels within their reference ranges. The management of subclinical thyroid dysfunction is controversial. The...

  • DYSLIPIDAEMIA AND HYPERTENSION IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM. Velkoska Nakova, V.; Krstevska, B.; Bosevski, M.; Dimitrovski, Ch.; Serafimoski, V. // Contributions of Macedonian Academy of Sciences & Arts;2009, Vol. 30 Issue 2, p93 

    Objective. The aim of this study was to assess whether subclinical hypothyroidism (SCH) is associated with dyslipidaemia and arterial hypertension. Methods. At the Department of Endocrinology, Diabetes and Metabolic Disorders, Skopje, R. Macedonia, we examined 24 consecutive patients with SCH...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics